Reactive Oxygen Species
- Name
- Reactive Oxygen Species
- Accession Number
- DBCAT001389
- Description
Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of signal transduction and gene expression, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.
- Drugs
Drug Drug Description Artesunate Artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria. Hydrogen peroxide A compound used as a disinfectant and sterilizer. Carbamide peroxide A medication used to loosen ear wax, whiten teeth, and clean oral wounds. Hypochlorous acid An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent. Hypochlorite An antimicrobial used to treat and prevent infections of the skin and tissue. Prostaglandin G2 A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem] Artefenomel Artefenomel has been investigated for the treatment of Malaria. Magnesium peroxide Not Annotated Artemether An antimalarial agent used in combination with lumefantrine for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum. Artenimol For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB13941. Artemisinin A medication indicated in the treatment of malaria. Artemotil Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria... Artemisone Artemisone is under investigation in clinical trial NCT00936767 (Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia). - Drugs & Drug Targets